Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2003-3-18
pubmed:abstractText
A modestly elevated total plasma homocysteine concentration (tHcy) is generally accepted as an independent and graded risk factor for various pathologies, including vascular diseases, neural tube defects, Alzheimer disease, and pregnancy complications. We analyzed 5 common functional polymorphisms in enzymes involved in homocysteine metabolism (ie, methylenetetrahydrofolate reductase [MTHFR] 677C>T and 1298A>C, methionine synthase [MTR] 2756A>G, cystathionine beta-synthase [CBS] 844ins68, and methionine synthase reductase [MTRR] 66A>G) in 452 young adults, and quantified their independent and interactive effects on tHcy concentrations. Serum folate, red cell folate, vitamin B(12), and tHcy concentrations were significantly influenced by MTHFR 677C>T genotypes. A particularly strong interaction was observed between the MTHFR 677TT genotype and serum folate, which led to a high tHcy phenotype that was more pronounced in males. The genetic contribution to the variance in tHcy was estimated to be approximately 9%, compared with approximately 35% that could be attributed to low folate and vitamin B(12). Our study indicates that dietary factors are centrally important in the control of tHcy levels in young adults with additional, but somewhat weaker, genetic effects. These data underscore the potential benefits that may be gained by improving the dietary status of young adults, and provide support for the implementation of folate/B-vitamin food fortification programs.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
101
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2483-8
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:12642343-5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase, pubmed-meshheading:12642343-Adult, pubmed-meshheading:12642343-Cystathionine beta-Synthase, pubmed-meshheading:12642343-Female, pubmed-meshheading:12642343-Ferredoxin-NADP Reductase, pubmed-meshheading:12642343-Folic Acid, pubmed-meshheading:12642343-Genetic Predisposition to Disease, pubmed-meshheading:12642343-Genotype, pubmed-meshheading:12642343-Homocysteine, pubmed-meshheading:12642343-Humans, pubmed-meshheading:12642343-Hyperhomocysteinemia, pubmed-meshheading:12642343-Male, pubmed-meshheading:12642343-Methylenetetrahydrofolate Reductase (NADPH2), pubmed-meshheading:12642343-Mutation, pubmed-meshheading:12642343-Nutritional Status, pubmed-meshheading:12642343-Oxidoreductases Acting on CH-NH Group Donors, pubmed-meshheading:12642343-Polymorphism, Genetic, pubmed-meshheading:12642343-Vitamin B 12
pubmed:year
2003
pubmed:articleTitle
Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults.
pubmed:affiliation
Department of Pharmacology and Center for Pharmacogenetics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't